Pharma Pulse 11/6/24: Enacting Sustainable Practices, Pharmacist Provider Status Is Growing & more

Enacting Sustainable Practices

In the third part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Delphine Perridy, chief commercial officer, Envirotainer, discusses the significant increase in demand for sustainable practices and outlines the company's initiatives in this area.

Pharmacist Provider Status Is Growing. Now What?

Throughout a new graduate’s career, that provider status will become mainstream.

From A.I. to Musk’s Brain Chips, the F.D.A.’s Device Unit Faces Rapid Change

The new director overseeing medical devices will confront criticisms about hasty approvals as she ushers in revolutionary technology.

NJ Bio and Charles River Announce a Strategic Alliance to Advance ADC Development and Manufacturing Services

NJ Bio, Inc. and Charles River Laboratories, Inc. announced a strategic alliance to offer complementary services to clients including early development and optimization to manufacturing of antibody drug conjugates (ADCs).

Takeda Oncology on LinkedIn

As the #oncology industry adjusts to evolving policies, creative solutions are on the horizon. Whether it be through collaboration, or leveraging new tech and #AI, it’s crucial we adapt our approach to continue meeting the needs of people living with #cancerand ensuring access to new and existing medications. Our own Liz Lewis, Head, Global Oncology Pricing, Value and Access, recently shared her thoughts on the changing policy landscape with Pharmaceutical Executive. Read the full article below.

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs